Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention	Nausea, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Nausea and Vomiting, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting	Enrolling by invitation	Not applicable	2025-03-30		NCT05773950

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Samsung Medical Center	207

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Samsung Medical Center	Seoul	South Korea	42

Clinical trials